- Poster presentation
- Open Access
Coronary magnetic resonance angiography combined with stress-perfusion and delayed-enhancement magnetic resonance imaging for the detection of occult coronary artery disease in asymptomatic individuals
© Song et al.; licensee BioMed Central Ltd. 2014
- Published: 16 January 2014
- Coronary Artery Stenosis
- Significant Coronary Artery Disease
- Regional Wall Motion Abnormality
- Diagnostic Image Quality
- Coronary Artery Segment
To evaluate the feasibility of using coronary magnetic resonance angiography (CMRA) with stress-perfusion and delayed-enhancement MRI as a screening tool for detection of coronary artery disease in asymptomatic patients.
Three hundred forty-one self-referred asymptomatic subjects were enrolled in this study. CMRA image quality and factors affecting image quality were evaluated using a 1.5-T scanner with a 32-channel cardiac coil. Coronary artery stenosis, regional wall motion abnormalities, myocardial perfusion abnormalities, and delayed myocardial enhancement were analyzed. The occurrence of new chest pain and cardiac events was assessed with review of medical records and by telephone interviews in 332 subjects (97.3%) during the 29 ± 6 months (range, 18 to 39 months) follow-up period.
A total of 3296 (82.4%) of 4000 coronary artery segments exhibited diagnostic image quality on combined whole-heart and volume-targeted MRA. Image quality was affected by heart rates and navigator efficiency in whole-heart CMRA, and heart rates and ages in volume-targeted CMRA. Combined MRI detected significant coronary artery stenosis in eleven (3%) of 341 subjects. Three subjects (0.9%) underwent percutaneous coronary intervention after coronary artery disease was detected on cardiac MRI. There were no cardiac events during the follow-up period in subjects with follow-up.
Coronary MRA combined with stress-perfusion and delayed enhancement MRI may help to rule out significant coronary artery disease in asymptomatic individuals.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.